Sahajanand Medical Technologies IPO — GMP Today, Price Band & Dates

Sahajanand Medical Technologies
GMP ▲ 17
Closed
Date15-19 Oct 2026
IPO Price: ₹344
Est. Listing: ₹361 (4.94%)
Type: Mainboard

Sahajanand Medical Technologies IPO GMP Today

The current grey market premium (GMP) of the Sahajanand Medical Technologies IPO is ₹17. GMP reflects unofficial demand for the shares before listing and moves with market sentiment and subscription numbers. This figure updates automatically every hour.

Key Details

IPO NameSahajanand Medical Technologies
TypeMainboard
IPO Dates15-19 Oct 2026
Price Band₹344
GMP Today₹17
Estimated Listing₹361 (4.94%)
StatusClosed

Live data last refreshed: 16/11/2026, 17:26:32 IST

FAQ

What is the GMP of Sahajanand Medical Technologies IPO today?

Sahajanand Medical Technologies IPO GMP today is ₹17.

What are the Sahajanand Medical Technologies IPO dates?

Sahajanand Medical Technologies IPO dates: 15-19 Oct 2026.

Is Sahajanand Medical Technologies a Mainboard or SME IPO?

Sahajanand Medical Technologies is a Mainboard IPO.

Does GMP guarantee listing gains?

No. GMP is an unofficial, unregulated indicator and can change quickly. Always evaluate the company's fundamentals before investing.

About Sahajanand Medical Technologies

Sahajanand Medical Technologies Limited is an R&D-driven company incorporated in 2001 that develops Class III and Class C/D medical devices with an emphasis on Vascular Intervention and Structural Heart segments. Headquartered in Surat and Mumbai, the company operates three manufacturing facilities—two in India and one in Thailand. It markets its products globally, reaching 65 countries in the three months ended June 30, 2026, and 77 countries in Fiscal 2026, using direct, hybrid, and distributor-led models.

Business Model

The company earns revenue primarily through the sale of medical device products categorized into Vascular Intervention devices, Structural Heart devices, and other products including traded goods, renal stents, and peripheral drug-coated balloons. It serves customers such as hospitals, interventional cardiologists, surgeons, healthcare professionals, purchasing agents, government agencies, and distributors across India, Europe, and the Rest of the World.

Financial Performance

MetricFY24FY25FY26
Revenue from operations9,016.0410,248.7912,105.04
EBITDA1,100.471,280.211,706.55
Profit after tax-73.54251.52690.82
Net worth5,263.035,452.326,160.51
Total borrowings1,752.692,249.572,695.26
EBITDA margin12.21%12.49%14.10%
PAT margin-0.82%2.45%5.71%

Figures as disclosed in the DRHP/RHP filed with the stock exchange. Source: offer document.

Objects of the Issue

Promoters

The promoters of the company are Bhargav Dhirajlal Kotadia (Managing Director and CEO), Dhirajlal Vallabhbhai Kotadia (Chairman Emeritus), Priyanka Dhirajlal Cohen, and Shree Hari Trust, a private family trust.

Strengths

Key Risks

Points to Weigh

This page is updated automatically as the IPO progresses — price band, dates and live GMP appear above once announced. Nothing here is investment advice.